SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+20.08%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.37B
AUM Growth
+$183M
(+8.4%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-7.51%
Top 10 Holdings %
Top 10 Hldgs %
42.39%
Holding
113
New
23
Increased
16
Reduced
30
Closed
11
Top Buys
| 1 |
Coca-Cola
KO
|
$33.4M |
| 2 |
Apple
AAPL
|
$30.3M |
| 3 |
CRH
CRH
|
$28.9M |
| 4 |
ArriVent BioPharma
AVBP
|
$27.9M |
| 5 |
argenx
ARGX
|
$26.9M |
Top Sells
| 1 |
Arcellx
ACLX
|
$60.8M |
| 2 |
Royalty Pharma
RPRX
|
$49.7M |
| 3 |
Las Vegas Sands
LVS
|
$36.3M |
| 4 |
Microsoft
MSFT
|
$34.8M |
| 5 |
Biohaven
BHVN
|
$31.2M |
Sector Composition
| 1 | Healthcare | 65.84% |
| 2 | Technology | 8.92% |
| 3 | Communication Services | 8% |
| 4 | Consumer Discretionary | 5.07% |
| 5 | Financials | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Microsoft
MSFT
$3.78T
| $33.4M | 1.24% |
79,317
-82,607
| -51% | -$34.8M |
|
27
Sutro Biopharma
STRO
$86.5M
| $32.6M | 1.21% |
5,778,188
| – | – |
|
28
McKesson
MCK
$86B
| $30.4M | 1.13% |
56,639
-6,821
| -11% | -$3.66M |
|
|
29
Apple
AAPL
$3.56T
| $30.3M | 1.13% |
+176,680
| New | +$30.3M |
|
|
30
CRH
CRH
$74.9B
| $28.9M | 1.08% |
+335,580
| New | +$28.9M |
|
|
31
ArriVent BioPharma
AVBP
$792M
| $27.9M | 1.04% |
+1,563,709
| New | +$27.9M |
|
32
Fulcrum Therapeutics
FULC
$372M
| $26.9M | 1% |
2,848,486
-2,670,395
| -48% | -$25.2M |
|
33
Elevance Health
ELV
$69.4B
| $26.4M | 0.98% |
50,925
-2,810
| -5% | -$1.46M |
|
34
Oracle
ORCL
$626B
| $24.7M | 0.92% |
196,674
-125,376
| -39% | -$15.7M |
|
35
Chipotle Mexican Grill
CMG
$55.5B
| $23.2M | 0.86% |
398,500
-37,000
| -8% | -$2.15M |
|
|
BCYC
36
Bicycle Therapeutics
BCYC
$483M
| $22.8M | 0.85% |
914,476
| – | – |
|
37
PepGen
PEPG
$42M
| $22.4M | 0.83% |
1,520,932
+1,034,321
| +213% | +$15.2M |
|
38
Boston Scientific
BSX
$159B
| $20.8M | 0.77% |
303,035
-391,066
| -56% | -$26.8M |
|
39
Fate Therapeutics
FATE
$112M
| $18.8M | 0.7% |
+2,562,852
| New | +$18.8M |
|
40
Arcus Biosciences
RCUS
$1.23B
| $18.1M | 0.67% |
957,304
| – | – |
|
41
Hilton Worldwide
HLT
$65.4B
| $16.7M | 0.62% |
78,502
-30,760
| -28% | -$6.56M |
|
42
Salesforce
CRM
$233B
| $16.6M | 0.62% |
+55,050
| New | +$16.6M |
|
43
Starbucks
SBUX
$98.9B
| $15.8M | 0.59% |
+172,951
| New | +$15.8M |
|
44
Johnson & Johnson
JNJ
$431B
| $14.3M | 0.53% |
90,097
| – | – |
|
45
Global Payments
GPN
$21.2B
| $14.2M | 0.53% |
106,094
-6,286
| -6% | -$840K |
|
46
Pinterest
PINS
$25.2B
| $13.7M | 0.51% |
+395,851
| New | +$13.7M |
|
|
MREO
47
Mereo BioPharma
MREO
$275M
| $12.1M | 0.45% |
3,653,494
-3,717,344
| -50% | -$12.3M |
|
48
Sanofi
SNY
$111B
| $10.2M | 0.38% |
210,701
+39,700
| +23% | +$1.93M |
|
49
Immatics
IMTX
$695M
| $9.95M | 0.37% |
+946,563
| New | +$9.95M |
|
50
Terns Pharmaceuticals
TERN
$618M
| $8.95M | 0.33% |
1,363,675
-4,473,451
| -77% | -$29.3M |
|